I also agree with your logic about "risk"
but total valuation of 4dx at 50c is $205m AUD which is less then petty cash for company earning $30b AUD !
now, normally biotech or medical devices company get take over before FDA approval make them cheaper target but this one already has FDA approval for a product so far cheaper deal for Phillip now on risk reward basis then to let it run !!!!!
Research, page-2794
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
50.0¢ |
Change
-0.020(3.85%) |
Mkt cap ! $205.2M | |||
| Open | High | Low | Value | Volume |
| 51.5¢ | 51.5¢ | 50.0¢ | $207.5K | 409.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 133957 | 50.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 51.0¢ | 7340 | 1 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |